Switch theme
Sign up to access all valuation multiples
Ambea AB is a provider of care in Sweden focused on disabled and elderly residential care in its own management units. The company's segment includes Nytida, Vardaga, Stendi, Altiden, and Klara. The Vardaga segment provides elderly care. The Nytida segment offers disability care. The Stendi segment comprises support for children and young people, personal assistance, residential care facilities, elderly care, and home care in Norway. The Altiden segment comprises operations in elderly care and home care; The Klara segment engages in staffing such as temporary doctors, nurses, and other care workers.
1903
35K+
LTM Revenue $1.5B
LTM EBITDA $282M
$2.1B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Ambea has a last 12-month revenue (LTM) of $1.5B and a last 12-month EBITDA of $282M.
In the most recent fiscal year, Ambea achieved revenue of $1.5B and an EBITDA of $270M.
Ambea expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Ambea valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $1.5B | XXX | $1.5B | XXX | XXX | XXX |
| Gross Profit | $1.5B | XXX | $1.4B | XXX | XXX | XXX |
| Gross Margin | 100% | XXX | 97% | XXX | XXX | XXX |
| EBITDA | $282M | XXX | $270M | XXX | XXX | XXX |
| EBITDA Margin | 18% | XXX | 18% | XXX | XXX | XXX |
| EBIT | $137M | XXX | $130M | XXX | XXX | XXX |
| EBIT Margin | 9% | XXX | 9% | XXX | XXX | XXX |
| Net Profit | $67.3M | XXX | $64.0M | XXX | XXX | XXX |
| Net Margin | 4% | XXX | 4% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $216M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Ambea's stock price is SEK 107 (or $11).
Ambea has current market cap of SEK 9.0B (or $926M), and EV of SEK 20.1B (or $2.1B).
See Ambea trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2.1B | $926M | XXX | XXX | XXX | XXX | $0.97 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Ambea has market cap of $926M and EV of $2.1B.
Ambea's trades at 1.4x EV/Revenue multiple, and 7.7x EV/EBITDA.
Equity research analysts estimate Ambea's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Ambea has a P/E ratio of 13.7x.
See valuation multiples for Ambea and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $926M | XXX | $926M | XXX | XXX | XXX |
| EV (current) | $2.1B | XXX | $2.1B | XXX | XXX | XXX |
| EV/Revenue | 1.4x | XXX | 1.4x | XXX | XXX | XXX |
| EV/EBITDA | 7.4x | XXX | 7.7x | XXX | XXX | XXX |
| EV/EBIT | 15.2x | XXX | 15.9x | XXX | XXX | XXX |
| EV/Gross Profit | 1.4x | XXX | n/a | XXX | XXX | XXX |
| P/E | 13.7x | XXX | 14.5x | XXX | XXX | XXX |
| EV/FCF | 22.4x | XXX | 10.3x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialAmbea's last 12 month revenue growth is 9%
Ambea's revenue per employee in the last FY averaged $42K, while opex per employee averaged $37K for the same period.
Ambea's rule of 40 is 26% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Ambea's rule of X is 40% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Ambea and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 9% | XXX | 8% | XXX | XXX | XXX |
| EBITDA Margin | 18% | XXX | 18% | XXX | XXX | XXX |
| EBITDA Growth | 8% | XXX | 13% | XXX | XXX | XXX |
| Rule of 40 | 26% | XXX | 27% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 40% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $42K | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $37K | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 0% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 88% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| National Healthcare Corp | XXX | XXX | XXX | XXX | XXX | XXX |
| Regis Healthcare | XXX | XXX | XXX | XXX | XXX | XXX |
| Maternus-Kliniken | XXX | XXX | XXX | XXX | XXX | XXX |
| Addus HomeCare | XXX | XXX | XXX | XXX | XXX | XXX |
| Amedisys | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Ambea acquired XXX companies to date.
Last acquisition by Ambea was XXXXXXXX, XXXXX XXXXX XXXXXX . Ambea acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Ambea founded? | Ambea was founded in 1903. |
| Where is Ambea headquartered? | Ambea is headquartered in Sweden. |
| How many employees does Ambea have? | As of today, Ambea has 35K+ employees. |
| Who is the CEO of Ambea? | Ambea's CEO is Mr. Mark Jensen. |
| Is Ambea publicy listed? | Yes, Ambea is a public company listed on STO. |
| What is the stock symbol of Ambea? | Ambea trades under AMBEA ticker. |
| When did Ambea go public? | Ambea went public in 2017. |
| Who are competitors of Ambea? | Similar companies to Ambea include e.g. National Healthcare Corp, Regis Healthcare, Maternus-Kliniken, Addus HomeCare. |
| What is the current market cap of Ambea? | Ambea's current market cap is $926M |
| What is the current revenue of Ambea? | Ambea's last 12 months revenue is $1.5B. |
| What is the current revenue growth of Ambea? | Ambea revenue growth (NTM/LTM) is 9%. |
| What is the current EV/Revenue multiple of Ambea? | Current revenue multiple of Ambea is 1.4x. |
| Is Ambea profitable? | Yes, Ambea is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Ambea? | Ambea's last 12 months EBITDA is $282M. |
| What is Ambea's EBITDA margin? | Ambea's last 12 months EBITDA margin is 18%. |
| What is the current EV/EBITDA multiple of Ambea? | Current EBITDA multiple of Ambea is 7.4x. |
| What is the current FCF of Ambea? | Ambea's last 12 months FCF is $93.0M. |
| What is Ambea's FCF margin? | Ambea's last 12 months FCF margin is 6%. |
| What is the current EV/FCF multiple of Ambea? | Current FCF multiple of Ambea is 22.4x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
